AbbVie. has filed a patent for a process to prepare a specific compound used in the treatment of rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis. The patent also covers the solid state forms of the compound, pharmaceutical compositions, synthesis methods, and products-by-process. GlobalData’s report on AbbVie gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights AbbVie Inc - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

According to GlobalData’s company profile on AbbVie, Peptide pharmacophores was a key innovation area identified from patents. AbbVie's grant share as of September 2023 was 45%. Grant share is based on the ratio of number of grants to total number of patents.

The patent filed is for a process to prepare a pharmaceutical composition for treating arthritis